BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1337431)

  • 21. Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines.
    Dong J; Naito M; Tatsuta T; Seimiya H; Johdo O; Tsuruo T
    Oncol Res; 1995; 7(5):245-52. PubMed ID: 8534930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
    Peer D; Dekel Y; Melikhov D; Margalit R
    Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.
    Baas F; Jongsma AP; Broxterman HJ; Arceci RJ; Housman D; Scheffer GL; Riethorst A; van Groenigen M; Nieuwint AW; Joenje H
    Cancer Res; 1990 Sep; 50(17):5392-8. PubMed ID: 1974823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-benzyladriamycin-14-valerate and drug resistance: correlation of anthracycline structural modification with intracellular accumulation and distribution in multidrug resistant cells.
    Lothstein L; Wright HM; Sweatman TW; Israel M
    Oncol Res; 1992; 4(8-9):341-7. PubMed ID: 1362503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
    Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
    Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II.
    Jensen PB; Jensen PS; Demant EJ; Friche E; Sørensen BS; Sehested M; Wassermann K; Vindeløv L; Westergaard O; Hansen HH
    Cancer Res; 1991 Oct; 51(19):5093-9. PubMed ID: 1655244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
    Tapiero H; Nguyen-Ba G; Lampidis TJ
    Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemical synthesis and biological properties of novel fluorescent antifolates in Pgp- and MRP-overexpressing tumour cell lines.
    Robson C; Wright KA; Twentyman PR; Lambert PA; Griffin RJ
    Biochem Pharmacol; 1998 Oct; 56(7):807-16. PubMed ID: 9774142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
    Rothenborg-Jensen L; Hansen HF; Wessel I; Nitiss JL; Schmidt G; Jensen PB; Sehested M; Jensen LH
    Anticancer Drug Des; 2001 Dec; 16(6):305-15. PubMed ID: 12375883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of cyclosporin A and buthionine sulfoximine (BSO) as a pharmacological strategy for circumvention of multidrug resistance in small cell lung cancer cell lines selected for resistance to doxorubicin.
    Larsson R; Bergh J; Nygren P
    Anticancer Res; 1991; 11(1):455-9. PubMed ID: 1850223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxicity studies of some novel fluoro acridone derivatives against sensitive and resistant cancer cell lines and their mechanistic studies.
    Rajendra Prasad VV; Peters GJ; Lemos C; Kathmann I; Mayur YC
    Eur J Pharm Sci; 2011 Jul; 43(4):217-24. PubMed ID: 21565270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The activity of deoxyspergualin in multidrug-resistant cells.
    Holmes JA; Twentyman PR
    Cancer Chemother Pharmacol; 1995; 36(6):499-505. PubMed ID: 7554042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro cytotoxic activity of novel protoflavone analogs - selectivity towards a multidrug resistant cancer cell line.
    Danko B; Martins A; Chuang DW; Wang HC; Amaral L; Molnár J; Chang FR; Wu YC; Hunyadi A
    Anticancer Res; 2012 Jul; 32(7):2863-9. PubMed ID: 22753749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amplification and expression of mdr1 gene in a multidrug resistant variant of small cell lung cancer cell line NCI-H69.
    Reeve JG; Rabbitts PH; Twentyman PR
    Br J Cancer; 1989 Sep; 60(3):339-42. PubMed ID: 2571355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential recognition of mdr1a and mdr1b gene products in multidrug resistant mouse tumour cell lines by different monoclonal antibodies.
    Barrand MA; Twentyman PR
    Br J Cancer; 1992 Feb; 65(2):239-45. PubMed ID: 1346747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression.
    Coley HM; Workman P; Twentyman PR
    Br J Cancer; 1991 Mar; 63(3):351-7. PubMed ID: 1672252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterisation of a mouse tumour cell line with in vitro derived resistance to verapamil.
    Twentyman PR; Wright KA; Fox NE
    Br J Cancer; 1990 Feb; 61(2):279-84. PubMed ID: 1968761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL).
    Jensen PB; Vindeløv L; Roed H; Demant EJ; Sehested M; Skovsgaard T; Hansen HH
    Br J Cancer; 1989 Dec; 60(6):838-44. PubMed ID: 2574988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemosensitisation of a drug-sensitive parental cell line by low-dose cyclosporin A.
    Twentyman PR; Wright KA
    Cancer Chemother Pharmacol; 1991; 29(1):24-8. PubMed ID: 1742845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circumvention of doxorubicin resistance in multi-drug resistant human leukaemia and lung cancer cells by the pure antioestrogen ICI 164384.
    Hu XF; Nadalin G; De Luise M; Martin TJ; Wakeling A; Huggins R; Zalcberg JR
    Eur J Cancer; 1991; 27(6):773-7. PubMed ID: 1648945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.